Notice of Intent to Sole Source – Metabolon Inc.

This acquisition is for biological sample testing for a diet intervention clinical research trial at the National Institutes of Health (NIH) Clinical Center (CC).

• Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies

• NAICS Code: 541380 – Testing Laboratories and Services

• Place of Performance: Bethesda, MD 20892 USA

POTS: 26-005190

Description:

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.

The National Institutes of Health (NIH) intends to award a fixed price purchase order to Metabolon, Inc., located at 617 Davis Dr. STE 400, Morrisville, NC 27560, on a firm fixed price sole source award basis to provide biological sample testing services to the National Institutes of Health.

The proposed vendor, Metabolon, Inc., specializes in the bioanalysis and data interpretation of metabolomics for the mechanistic understanding of biomarkers at a cellular level. Metabolon sets itself apart with superior analytical and bioinformatics technologies, which together produce high-quality data via a high-throughput workflow. Their proprietary bioinformatics technology rapidly sorts through massive amounts of biochemical data, extracting only significant information. Samples for this study have already been analyzed by Metabolon in previous years, and we want to limit variability of sample testing. It will be critical to put study results into context to compare our data from Metabolon to the results from similar clinical trials that performed testing at Metabolon.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by May 13, 2026 at 1pm EST.